glp-1 epilepsy Neuroprotective effects of glucagon-like peptide-1 (GLP-1) analogues in and associated comorbidities Could GLP-1 drugs affect risk

Feingold K.R., editor

Another Novo Nordisk semaglutide drug, Wegovy, is FDA-approved for weight loss and has proven more effective in causing clinically significant weight loss than Saxendas active ingredient, liraglutide

Based on the principle of disproportionality analysis, it can be divided into reporting odds Ratio (ROR) and proportional reporting ratio (PRR) according to the difference in algorithms

Aspirin and blood-thinning medications should be avoided for at least 24 hours before treatment

Research literature suggests that these sequence modifications may confer altered receptor affinity and prolonged functional persistence relative to the endogenous hormone, though outcomes appear to be context dependent